These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 520101)

  • 1. Influence of portacaval anastomosis on serum and biliary unsulfated bile acid composition in patients with liver cirrhosis.
    Angelico M; Attili AF; Bracci F; Di Biase A; Paciscopi L; Puoti C; Capocaccia L
    Dig Dis Sci; 1979 Nov; 24(11):829-34. PubMed ID: 520101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated bile acids in serum, bile, and urine of cirrhotic patients before and after portacaval anastomosis.
    Capocaccia L; Attili AF; Cantafora A; Bracci F; Paciscopi L; Puoti C; Pièche U; Angelico M
    Dig Dis Sci; 1981 Jun; 26(6):513-7. PubMed ID: 7238270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary deoxycholate in patients with alcoholic cirrhosis.
    Mehta SJ; Struthers JE; Kaye MD; Naylor JL
    Gastroenterology; 1974 Oct; 67(4):674-9. PubMed ID: 4412192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bile acid metabolism in hepatic tissue of healthy subjects and in patients with liver cirrhosis].
    Erb W; Haase A; Leuschner U
    Z Gastroenterol; 1973 Apr; 11(3):203-16. PubMed ID: 4803420
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.
    Stiehl A; Earnest DL; Admirant WH
    Gastroenterology; 1975 Mar; 68(3):534-44. PubMed ID: 1112455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
    Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids in hepatic bile in liver disease.
    Kuroda T; Okuda K
    Acta Hepatogastroenterol (Stuttg); 1974 Apr; 21(2):120-6. PubMed ID: 4450968
    [No Abstract]   [Full Text] [Related]  

  • 8. Bile acid metabolism and hepatic disease following small bowel bypass for obesity.
    Sherr HP; Nair PP; White JJ; Banwell JG; Lockwood DH
    Am J Clin Nutr; 1974 Dec; 27(12):1369-79. PubMed ID: 4432827
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
    Stiehl A; Raedsch R; Kommerell B
    Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfation of bile salts: a new metabolic pathway.
    Stiehl A
    Digestion; 1974; 11(5-6):406-13. PubMed ID: 4618540
    [No Abstract]   [Full Text] [Related]  

  • 12. Bile acid metabolism in mammals. VI. Effect of ethionine upon bile acids of rat bile.
    Kakis G; Fisher MM; Yousef IM
    Lipids; 1974 Jun; 9(6):407-14. PubMed ID: 4837888
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum and urinary bile acids in patients with primary biliary cirrhosis.
    Samuelson K; Aly A; Johansson C; Norman A
    Scand J Gastroenterol; 1982 Jan; 17(1):121-8. PubMed ID: 7134826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.
    Yoshida T; McCormick WC; Swell L; Vlahcevic ZR
    Gastroenterology; 1975 Feb; 68(2):335-41. PubMed ID: 1116679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
    Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
    Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.
    Hedenborg G; Jönsson G; Wisén O; Norman A
    Scand J Clin Lab Invest; 1991 Apr; 51(2):197-208. PubMed ID: 2042024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in serum bile acid composition between unoperated cirrhotic patients and patients with portacaval or mesocaval shunt.
    Angelico M; Attili AF; Cantafora A; Lombardi M; Thau A; Capocaccia L
    Digestion; 1979; 19(2):126-30. PubMed ID: 478189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid metabolism in benign recurrent intrahepatic cholestasis. Comparative studies on the icteric and anicteric phases of a single case.
    Endo T; Uchida K; Amuro Y; Higashino K; Yamamura Y
    Gastroenterology; 1979 May; 76(5 Pt 1):1002-6. PubMed ID: 437403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
    Salen G; Verga D; Batta AK; Tint GS; Shefer S
    Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gallbladder in gallstone formation.
    Nakayama F; van der Linden W
    Acta Chir Scand; 1974; 140(1):45-9. PubMed ID: 4819022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.